Atovaquone Oral Suspension 750Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Atovaquone: Oral suspension (750mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ATOVAQUONE (a TOE va kwone) is an anti-infective medicine. It is used to prevent and to treat Pneumocystis carinii pneumonia (PCP).

Similar Brand Name Drugs : Mepron: Oral suspension (750mg)
In-Depth Information
Select a Medication

ATOVAQUONE 750mg/5mL Suspension

NDC: 651620693
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Pneumocystis Pneumonia (PCP) Prophylaxis, Pneumocystis Pneumonia (PCP)

Sometimes used for but not FDA approved for the following conditions:
Toxoplasmosis Prophylaxis, Babesiosis, Toxoplasmosis, Toxoplasmic Encephalitis

Storage Information
Do not freeze
Store between 59 to 77 degrees F
ATOVAQUONE 750mg/5mL Suspension

Reported Side Effects for ATOVAQUONE 750mg/5mL Suspension

Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Keratopathy Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Methemoglobin Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Inability To Sleep Incidence:
<19.0%*
Severity: MILD
Onset: EARLY
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
0.6-40.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
1.0%*
Severity: MODERATE
Onset: RAPID
Low Blood Sugar Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Breathing Difficulties Incidence:
2.0-4.0%*
Severity: SEVERE
Onset: RAPID
Vomiting Incidence:
2.2-22.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
3.0-8.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
3.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
3.2-42.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
4.0-8.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
4.0-21.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
4.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
4.1-32.0%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
5.0-24.0%*
Severity: MILD
Onset: EARLY
Yeast Infection Incidence:
5.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
6.3-46.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
High Amylase Levels Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
7.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Weakness Incidence:
8.0-31.0%*
Severity: MILD
Onset: DELAYED
Increased Blood Sugar Incidence:
9.0%*
Severity: MODERATE
Onset: DELAYED
Excessive Sweating Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Flu Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Muscle Pain Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
>10.0%*
Severity: MILD
Onset: RAPID
Sinus Infection Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
14.0-25.0%*
Severity: MILD
Onset: DELAYED
Shortness Of Breath Incidence:
15.0-21.0%*
Severity: MODERATE
Onset: EARLY
Headache Incidence:
16.0-31.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
18.0-22.0%*
Severity: MILD
Onset: DELAYED
Rash With Pustules Incidence:
23.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Atovaquone

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5